These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22436042)

  • 21. Inflammatory bowel disease in women of reproductive age.
    De Felice KM; Kane SV
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):417-25. PubMed ID: 24580047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications.
    McConnell RA; Mahadevan U
    Gastroenterol Clin North Am; 2016 Jun; 45(2):285-301. PubMed ID: 27261899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of biologic agents in pregnancy and breastfeeding.
    Horst S; Kane S
    Gastroenterol Clin North Am; 2014 Sep; 43(3):495-508. PubMed ID: 25110255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory bowel disease: management issues during pregnancy.
    Ferrero S; Ragni N
    Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inflammatory bowel diseases in pregnancy].
    Gutkowski K; Hartleb M
    Ginekol Pol; 2009 May; 80(5):379-82. PubMed ID: 19548459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis.
    Gonzalez-Suarez B; Sengupta S; Moss AC
    World J Gastroenterol; 2017 Dec; 23(45):8082-8089. PubMed ID: 29259384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of inflammatory bowel diseases in pregnancy and lactation.
    Cassina M; Fabris L; Okolicsanyi L; Gervasi MT; Memmo A; Tiboni GM; Di Gianantonio E; Clementi M
    Expert Opin Drug Saf; 2009 Nov; 8(6):695-707. PubMed ID: 19832551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.
    Habal FM; Huang VW
    Aliment Pharmacol Ther; 2012 Mar; 35(5):501-15. PubMed ID: 22221203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
    de Boer NKH; Peyrin-Biroulet L; Jharap B; Sanderson JD; Meijer B; Atreya I; Barclay ML; Colombel JF; Lopez A; Beaugerie L; Marinaki AM; van Bodegraven AA; Neurath MF
    J Crohns Colitis; 2018 Apr; 12(5):610-620. PubMed ID: 29293971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary on " Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: A systematic review with meta-analysis".
    Kanis SL; Kreijne JE; van der Woude CJ
    Hum Exp Toxicol; 2017 Sep; 36(9):993-994. PubMed ID: 28111975
    [No Abstract]   [Full Text] [Related]  

  • 32. Thiopurines for inflammatory bowel disease: time to engage with dermatologists?
    Jess T
    Gastroenterology; 2011 Nov; 141(5):1549-51. PubMed ID: 21945060
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of the Pregnant Patient with Inflammatory Bowel Disease.
    Winter R; Nørgård BM; Friedman S
    Inflamm Bowel Dis; 2016 Mar; 22(3):733-44. PubMed ID: 26658216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).
    Shim L; Eslick GD; Simring AA; Murray H; Weltman MD
    J Crohns Colitis; 2011 Jun; 5(3):234-8. PubMed ID: 21575887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of high doses of mesalazine during pregnancy.
    Marteau P; Seksik P; Couve S; Jian R
    Am J Gastroenterol; 2005 Aug; 100(8):1897-8. PubMed ID: 16086733
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of inflammatory bowel disease and pregnancy: a review of the literature.
    Correia LM; Bonilha DQ; Ramos JD; Ambrogini O; Miszputen SJ
    Arq Gastroenterol; 2010; 47(2):197-201. PubMed ID: 20721468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inflammatory bowel disease and possible applications of tumor necrosis factor inhibitors in pregnant women].
    Li ED
    Eksp Klin Gastroenterol; 2013; (3):58-62. PubMed ID: 24294773
    [No Abstract]   [Full Text] [Related]  

  • 38. [Natural history, complications, safety and pregnancy in inflammatory bowel disease].
    Chaparro M
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():20-31. PubMed ID: 26520193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.
    van Asseldonk DP; Sanderson J; de Boer NK; Sparrow MP; Lémann M; Ansari A; Almer SH; Florin TH; Gearry RB; Mulder CJ; Mantzaris G; van Bodegraven AA;
    Dig Liver Dis; 2011 Apr; 43(4):270-6. PubMed ID: 20934926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [No fear of pregnancy].
    Stiefelhagen P
    MMW Fortschr Med; 2016 May; 158(10):88. PubMed ID: 27221450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.